Cyclophosphamide/docetaxel/doxorubicin/trastuzumab: Lymphoedema (first report for cyclophosphamide and trastuzumab): case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1361, 2011-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclophosphamide/docetaxel/doxorubicin: Extramedullary haematopoiesis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1253, 2009-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Antineoplastics: Panhypogammaglobulinaemia (first report with cyclophosphamide, doxorubicin, prednisone and vincristine): case report

By  

Reactions Weekly, Vol. 1, Iss. 1046, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/doxorubicin: First report of a fatal exacerbation of systemic scleroderma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1018, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Docetaxel/trastuzumab: Nail dystrophy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Docetaxel/lapatinib/trastuzumab: Pneumothoraces: case report

By  

Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite